Prevention and control of hypertension is a problem for the whole world. In addition to the prevailing medical policies, patient wishes, doctors' decision-making and other unfavorable factors, the use of multi-drug anti-hypertensive programs is insufficient, which seriously affects blood pressure control! In fact, compared with single-drug blood pressure, multi-drug antihypertensive treatment is better and easier to control blood pressure. There are still so many patients around the world who still use single-drug blood pressure, and rarely choose multi-drug regimen to reduce blood pressure? There are both psychological reasons for patients and reasons for doctors to make decisions. The patient's psychological resistance to multi-drug treatment, mistakenly believes that it is necessary to eat so many drugs when the condition of hypertension is very serious; and doctors often more conservatively recommend single-drug blood pressure, mainly because of the risk of superimposed side effects of multi-drug regimens. It is easy to cause the drug to stop affecting the blood pressure reduction effect . Is there a way to make medication more convenient during the treatment of hypertension, overcome the above challenges, and implement a multi-drug antihypertensive strategy to improve the efficacy? Quadpill is such a new anti-pressure strategy. It is a "four-in-one" single-capsule compound antihypertensive drug that allows patients to eat 4 capsules and eat 4 kinds of antihypertensive drugs. This may lead to new breakthroughs in the treatment of hypertension. â–² Quadpill's potential advantages in addressing the challenges of hypertension prevention and control (Source: Nature's official website) Quadpill has been used as an early antihypertensive drug in patients with newly diagnosed hypertension, and foreign researchers have done relevant clinical trials. The results of the trial confirmed the breakthrough efficacy of Quadpill treatment with unlimited potential. These trials have recently been published in the top medical journal The Lancet. Clinical implementation: In a double-blind randomized, placebo-crossover controlled clinical trial, 21 newly diagnosed hypertensive patients were randomized to the Quadpill treatment group and placebo treatment group, and discontinued for 2 weeks after 4 weeks of treatment. The two groups were then cross-treated for 4 weeks. All patients recorded two blood pressure values ​​(both in-hospital measurements and 24-hour dynamic monitoring outside the hospital) before treatment (baseline): the blood pressure values ​​measured in the hospital were called “office blood pressureâ€, and the hospital dynamics The monitored blood pressure value is called “outpatient blood pressureâ€. At baseline (pre-treatment), these patients had an average of 154/90 mmHg for "office blood pressure" and an average of 140/87 mmHg for "outpatient blood pressure."
Gunsafe is made of strong thick solid steel.After multiple physical tests to ensure that your valuables can be stored safely.
This gun safebox is in high strength and solid structure. Smart technology secures contents away from kids, and others. Reliable lock mechanism lock away with the electronic keypad by creating your own PIN code or lock it with the backup key.For quick access, instantly unlock the safe with a reliable PIN code,Prevents children and others from reaching inside.
The inside is large and deep enough for-7long guns (between 37in and 50in). 3 standard pistols and magazine accessories can be placed on the door panel. The upper adjusting plate can be adjusted and disassembled to adapt to different situations.
If you are considering buying Gun Safe, please feel free to contact us online to negotiate, we as a gunsafe production factory to provide you with high quality and low price products,
Non Fireproof Gunsafe,Storage Gun Safe,Electronic Gun Cabinet Safe,Anti Theft Gun Safe Box,Digital code keyboard gun safe Hebei Hupai Aodi Cabinet Industry Co.,Ltd. , https://www.aodicabinet.com
